Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,860
-520 (-3.62%)
At close: Jun 27, 2025, 3:30 PM KST
7.53%
Market Cap 249.08B
Revenue (ttm) 272.12B
Net Income (ttm) 11.34B
Shares Out 17.97M
EPS (ttm) 631.29
PE Ratio 21.95
Forward PE n/a
Dividend 150.00 (1.04%)
Ex-Dividend Date Dec 27, 2024
Volume 96,101
Average Volume 132,564
Open 14,370
Previous Close 14,380
Day's Range 13,790 - 14,380
52-Week Range 9,540 - 15,550
Beta 0.68
RSI 53.40
Earnings Date Aug 13, 2025

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 670
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.